Here, nine single-nucleotide polymorphisms of the NRF2 gene were analyzed in 452 patients with breast cancer and 370 controls while the subsequent protein expression analysis revealed high cytoplasmic NRF2 positivity in 66% (237 of 361) and nuclear positivity in 26% (96 of 365) of the cases. Here, NFE2L2 is linked to breast carcinoma.